Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar A Jaimes

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Seminars in Nephrology|March 5, 2020
Renal Toxicity of Systemic Therapy for Renal Cell CarcinomaEdgar A Jaimes
International Journal of Molecular Sciences|March 27, 2013
Mitochondria and reactive oxygen species: physiology and pathophysiologySubhashini Bolisetty, Edgar A Jaimes
Expert Review of Cardiovascular Therapy|March 7, 2012
Aliskiren, amlodipine and hydrochlorothiazide triple combination for hypertensionEric Judd, Edgar A Jaimes
American Journal of Physiology. Renal Physiology|April 7, 2017
Renal cell carcinoma: new insights and challenges for a clinician scientistRoman Shingarev, Edgar A Jaimes
The Journal of Nutrition|October 7, 2004
Role of L-arginine in the pathogenesis and treatment of renal diseaseGautam Cherla, Edgar A Jaimes
Biochemical Pharmacology|July 30, 2013
Nicotine signaling and progression of chronic kidney disease in smokersGaurav Jain, Edgar A Jaimes
Current Hypertension Reports|March 17, 2007
Cigarette smoking as a risk factor for atherosclerosis and renal disease: novel pathogenic insightsCarlos Mercado, Edgar A Jaimes
Antioxidants (Basel, Switzerland)|July 5, 2018
Transcription Factor ETS-1 and Reactive Oxygen Species: Role in Vascular and Renal InjuryYan-Ting Shiu, Edgar A Jaimes
Integrated Blood Pressure Control|July 10, 2013
Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combinationMichael B Hovater, Edgar A Jaimes
Current Opinion in Nephrology and Hypertension|February 22, 2002
Nitric oxide synthase and hypertensionBaudouin Leclercq, Edgar A Jaimes, Leopoldo Raij
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Seminars in Nephrology|March 5, 2020
Renal Toxicity of Systemic Therapy for Renal Cell CarcinomaEdgar A Jaimes
International Journal of Molecular Sciences|March 27, 2013
Mitochondria and reactive oxygen species: physiology and pathophysiologySubhashini Bolisetty, Edgar A Jaimes
Expert Review of Cardiovascular Therapy|March 7, 2012
Aliskiren, amlodipine and hydrochlorothiazide triple combination for hypertensionEric Judd, Edgar A Jaimes
American Journal of Physiology. Renal Physiology|April 7, 2017
Renal cell carcinoma: new insights and challenges for a clinician scientistRoman Shingarev, Edgar A Jaimes
The Journal of Nutrition|October 7, 2004
Role of L-arginine in the pathogenesis and treatment of renal diseaseGautam Cherla, Edgar A Jaimes
Biochemical Pharmacology|July 30, 2013
Nicotine signaling and progression of chronic kidney disease in smokersGaurav Jain, Edgar A Jaimes
Current Hypertension Reports|March 17, 2007
Cigarette smoking as a risk factor for atherosclerosis and renal disease: novel pathogenic insightsCarlos Mercado, Edgar A Jaimes
Antioxidants (Basel, Switzerland)|July 5, 2018
Transcription Factor ETS-1 and Reactive Oxygen Species: Role in Vascular and Renal InjuryYan-Ting Shiu, Edgar A Jaimes
Integrated Blood Pressure Control|July 10, 2013
Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combinationMichael B Hovater, Edgar A Jaimes
Current Opinion in Nephrology and Hypertension|February 22, 2002
Nitric oxide synthase and hypertensionBaudouin Leclercq, Edgar A Jaimes, Leopoldo Raij
Pageof 10